Cargando…
Informal caregivers experience of supplemental oxygen in pulmonary fibrosis
BACKGROUND: Patients prescribed supplemental oxygen (O(2)) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O(2) is brought into their...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494136/ https://www.ncbi.nlm.nih.gov/pubmed/28668090 http://dx.doi.org/10.1186/s12955-017-0710-0 |
_version_ | 1783247627080433664 |
---|---|
author | Graney, Bridget A. Wamboldt, Frederick S. Baird, Susan Churney, Tara Fier, Kaitlin Korn, Marjorie McCormick, Mark Vierzba, Thomas Swigris, Jeffrey J. |
author_facet | Graney, Bridget A. Wamboldt, Frederick S. Baird, Susan Churney, Tara Fier, Kaitlin Korn, Marjorie McCormick, Mark Vierzba, Thomas Swigris, Jeffrey J. |
author_sort | Graney, Bridget A. |
collection | PubMed |
description | BACKGROUND: Patients prescribed supplemental oxygen (O(2)) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O(2) is brought into their home and added to their lives. Our aim was to understand the multiple effects of supplemental oxygen therapy on ICs of patients with PF. METHODS: We conducted single, semi-structured telephone interviews with twenty ICs of patients with PF who were using O(2) for at least 8 months. We performed a qualitative, content analysis based in grounded theory to examine data across subjects. RESULTS: ICs initially reacted to O(2) with trepidation and sadness as they came to recognize the changes it would cause in the lives of their patient-loved one (PLO). ICs recognized both beneficial and negative effects of O(2) on their PLOs. ICs also realized that O(2) created significant changes in their own lives, including introducing new roles and responsibilities for them, altering their home environments and significantly impacting their relationships with their PLOs. Although O(2) was a tangible and constant reminder of disease progression, over time ICs were able to adapt and accept their new lives with O(2). CONCLUSION: ICs of patients with PF experience many life changes when their PLO is prescribed O(2). Having O(2) prescribers anticipate and recognize these challenges provides an opportunity to give support and guidance to ICs of PF patients who require O(2) in the hopes of limiting the negative impact of O(2) on their lives. TRIAL REGISTRATION: Clinicaltrials.gov, registration number NCT01961362. Registered 9 October 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-017-0710-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5494136 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54941362017-07-05 Informal caregivers experience of supplemental oxygen in pulmonary fibrosis Graney, Bridget A. Wamboldt, Frederick S. Baird, Susan Churney, Tara Fier, Kaitlin Korn, Marjorie McCormick, Mark Vierzba, Thomas Swigris, Jeffrey J. Health Qual Life Outcomes Research BACKGROUND: Patients prescribed supplemental oxygen (O(2)) therapy face challenges as they adjust to being constantly “tethered” to an oxygen delivery device. Informal caregivers (ICs) of patients with pulmonary fibrosis (PF) face their own, often overlooked hardships when O(2) is brought into their home and added to their lives. Our aim was to understand the multiple effects of supplemental oxygen therapy on ICs of patients with PF. METHODS: We conducted single, semi-structured telephone interviews with twenty ICs of patients with PF who were using O(2) for at least 8 months. We performed a qualitative, content analysis based in grounded theory to examine data across subjects. RESULTS: ICs initially reacted to O(2) with trepidation and sadness as they came to recognize the changes it would cause in the lives of their patient-loved one (PLO). ICs recognized both beneficial and negative effects of O(2) on their PLOs. ICs also realized that O(2) created significant changes in their own lives, including introducing new roles and responsibilities for them, altering their home environments and significantly impacting their relationships with their PLOs. Although O(2) was a tangible and constant reminder of disease progression, over time ICs were able to adapt and accept their new lives with O(2). CONCLUSION: ICs of patients with PF experience many life changes when their PLO is prescribed O(2). Having O(2) prescribers anticipate and recognize these challenges provides an opportunity to give support and guidance to ICs of PF patients who require O(2) in the hopes of limiting the negative impact of O(2) on their lives. TRIAL REGISTRATION: Clinicaltrials.gov, registration number NCT01961362. Registered 9 October 2013. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12955-017-0710-0) contains supplementary material, which is available to authorized users. BioMed Central 2017-07-01 /pmc/articles/PMC5494136/ /pubmed/28668090 http://dx.doi.org/10.1186/s12955-017-0710-0 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Graney, Bridget A. Wamboldt, Frederick S. Baird, Susan Churney, Tara Fier, Kaitlin Korn, Marjorie McCormick, Mark Vierzba, Thomas Swigris, Jeffrey J. Informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
title | Informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
title_full | Informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
title_fullStr | Informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
title_full_unstemmed | Informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
title_short | Informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
title_sort | informal caregivers experience of supplemental oxygen in pulmonary fibrosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494136/ https://www.ncbi.nlm.nih.gov/pubmed/28668090 http://dx.doi.org/10.1186/s12955-017-0710-0 |
work_keys_str_mv | AT graneybridgeta informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT wamboldtfredericks informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT bairdsusan informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT churneytara informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT fierkaitlin informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT kornmarjorie informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT mccormickmark informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT vierzbathomas informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis AT swigrisjeffreyj informalcaregiversexperienceofsupplementaloxygeninpulmonaryfibrosis |